Question to the Department of Health and Social Care:
To ask Her Majesty’s Government what assessment they have made of (1) the outcome, and (2) the cost effectiveness, of the use of faecal microbiota transplants in the treatment of recurrent clostridium difficile.
The National Institute for Health and Care Excellence (NICE) has produced guidance on faecal microbiota transplant for recurrent Clostridium difficile infection. NICE has recommended that the procedure is safe and effective for use in the National Health Service, but no assessment of its cost effectiveness has been made by NICE.
Data on the uptake of faecal microbiota transplants in the treatment of recurrent Clostridium difficile by the NHS is not collected centrally.